阿部 雄太

専任講師
阿部 雄太(あべ ゆうた)
1998年 慶應義塾大学医学部卒
     日本消化器外科学会指導医
     日本肝胆膵外科学会高度技能専門医
     日本内視鏡外科学会技術認定医(肝臓)

専門領域
腹腔鏡下解剖学的肝切除、肝胆膵血管合併切除、
ナビゲーション手術、肝門部胆管癌手術
コメント
低浸襲治療の代表である腹腔鏡下肝切除に最新の手術ナビゲーションを応用することで従来の肝切除を超えた精緻な肝切除を実践しています。一方で直径2mmの肝動脈に対するマイクロ血管吻合や重要大血管の合併切除再建を駆使した難治性腫瘍の拡大手術、つまり諦めない治療にも積極的に取り組んでいます。豊富な経験とあらゆる最新技術を駆使して、すべての患者様に全力で向き合うことによる「後悔しない治療」を追求します。

経歴

1998年慶應義塾大学医学部外科 研修医
2002年京都大学移植外科 医員
2004年医療財団法人荻窪病院外科 医員
2006年米国Louisiana州立大学分子生物学教室・外科学教室 研究員
2009年東京医科大学八王子医療センター 消化器外科・移植外科 助教
2012年慶應義塾大学病院 一般・消化器外科 助教
2015年慶應義塾大学病院 一般・消化器外科 専任講師(学部内)
2018年慶應義塾大学病院 一般・消化器外科 専任講師

主たる研究内容

1.血管合併切除を伴う切除困難症例に対する多科横断的治療
2.肝門部領域癌に対する血管合併切除とあらたな手術戦略
3.腹腔鏡下肝切除術
4.肝臓・膵臓・胆道領域の手術ナビゲーション

資格


所属学会


受賞歴

2014年日本内視鏡外科学会 カールストルツ賞(学会ベストビデオ賞2014)
2008年ルイジアナ州立大学リサーチグランドアワード 2008
2003年慶應義塾大学外科胆道班ベストレジデント2003

助成金

2014年度
~2016年度
新規の遺伝子網羅的解析法による肝細胞癌分子標的薬に対する薬剤耐性遺伝子の同定
:文科省科学研究費 基盤研究(C)
2010年度
~2011年度
小腸グラフト遊走性抗原特異的制御性T細胞導入による小腸移植後免疫寛容誘導法の確立
:文科省科学研究費 若手研究(B)

論文

1.Ishikawa J, Oshima M, Iwasaki F, Suzuki R, Park J, Nakao K, Matsuzawa-Adachi Y, Mizutsuki T, Kobayashi A, Abe Y, Kobayashi E, Tezuka K, Tsuji T. Hypothermic temperature effects on organ survival and restoration. Sci Rep. 2015 Apr;5:9563.
2.Tanaka M, Kitago M, Akiyama N, Iwamaru A, Yamamoto T, Suzuki F, Hibi T, Abe Y, Yagi H, Shinoda M, Itano O, Ogata K, Kitagawa Y. Usefulness of immunohistochemical studies in diagnosing metachronous gallbladder and small intestinal metastases from lung cancer with gastrointestinal hemorrhage: a case report. World J Surg Oncol. 2015 Feb;13(1):63.
3.Shinoda M, Kishida N, Itano O, Ei S, Ueno A, Kitago M, Abe Y, Hibi T, Yagi H, Masugi Y, Tanabe M, Aiura K, Sakamaoto M, Tanimoto A, Kitagawa Y. Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature. World J Surg Oncol. 2015 Apr;13(1):144.
4.Yamada T, Okabayashi K, Hasegawa H, Tsuruta M, Abe Y, Ishida T, Matsui S, Kitagawa Y. Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery. Ann Surg Oncol. 2015 Mar; Epub ahead of print.
5.Itano O, Oshima G, Minagawa T, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Ikoma N, Aiko S, Kawaida M, Masugi Y, Kameyama K, Sakamoto M, Kitagawa Y. Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc. 2015 Mar; Epub ahead of print.
6.Hibi T, Shinoda M, Itano O, Obara H, Kitago M, Abe Y, Yagi H, Tanaka M, Hoshino K, Fujino A, Kuroda T, Kawachi S, Tanabe M, Shimazu M, Kitagawa Y. Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis. Hepatol Res. 2015 Jan; Epub ahead of print.
7.Kishida N, Hibi T, Itano O, Okabayashi K, Shinoda M, Kitago M, Abe Y, Yagi H, Kitagawa Y. Validation of Hepatectomy for Elderly Patients with Hepatocellular Carcinoma. Ann Surg Oncol. 2015 Jan; Epub ahead of print.
8.Tanaka M, Shinoda M, Takayanagi A, Oshima G, Nishiyama R, Fukuda K, Yagi H, Hayashida T, Masugi Y, Suda K, Yamada S, Miyasho T, Hibi T, Abe Y, Kitago M, Obara H, Itano O, Takeuchi H, Sakamoto M, Tanabe M, Maruyama I, Kitagawa Y. Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model. J Surg Res. 2015 Apr;194(2):571-80.
9.Ei S, Hibi T, Tanabe M, Itano O, Shinoda M, Kitago M, Abe Y, Yagi H, Okabayashi K, Sugiyama D, Wakabayashi G, Kitagawa Y. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. Ann Surg Oncol. 2015 Apr;22(4):1294-300.
10.Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, Hasegawa Y, Katagiri T, Takagi C, Itano O, Kaneko H, Wakabayashi G. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53.
11.Kishida N, Shinoda M, Masugi Y, Itano O, Fujii-Nishimura Y, Ueno A, Kitago M, Hibi T, Abe Y, Yagi H, Tanimoto A, Tanabe M, Sakamaoto M, Kitagawa Y. Cystic tumor of the liver without ovarian-like stroma or bile duct communication: two case reports and a review of the literature. World J Surg Oncol. 2014 Jul 21;12:229.
12.Abe Y, Itano O, Kitago M, Shinoda M, Yagi H, Hibi T, Takano K, Chiba N, Kawachi S, Shimazu M, Kitagawa Y. Computer assisted surgery, preoperative planning and navigation for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2014 Apr;21(4):251-5.
13.Kadota Y, Yagi H, Inomata K, Matsubara K, Hibi T, Abe Y, Kitago M, Shinoda M, Obara H, Itano O, Kitagawa Y. Mesenchymal stem cells support hepatocyte function in engineered liver grafts. Organogenesis. 2014 Apr 1;10(2):268-77.
14.Shinoda M, Kadota Y, Tsujikawa H, Masugi Y, Itano O, Ueno A, Mihara K, Hibi T, Abe Y, Yagi H, Kitago M, Kawachi S, Tanimoto A, Sakamoto M, Tanabe M, Kitagawa Y. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Surg Oncol. 2013 May 4;11:97.
15.Kadota Y, Shinoda M, Tanabe M, Tsujikawa H, Ueno A, Masugi Y, Oshima G, Nishiyama R, Tanaka M, Mihara K, Abe Y, Yagi H, Kitago M, Itano O, Kawachi S, Aiura K, Tanimoto A, Sakamaoto M, Kitagawa Y. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review. World J Surg Oncol. 2013 Mar 21;11:75.
16.Abe Y, Kasuya K, Itoi T, Kikuchi S, Ikeuchi N, Ishii K, Serizawa H, Shimazu M. Hepatobiliary cystadenoma of the liver prolapsing into the extrahepatic bile duct (with video). Gastrointest Endosc. 2012 May;75(5):1099; discussion 1099-1100.
17.Kasuya K, Tsuchida A, Nagakawa Y, Suzuki Y, Suzuki M, Aoki T, Abe Y, Shimazu M, Itoi T, Sofuni A. Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. Hepatogastroenterology. 2012 Jul-Aug;59(117):1609-13.
18.Kasuya K, Tsuchida A, Nagakawa Y, Suzuki M, Abe Y, Itoi T, Serizawa H, Nagao T, Shimazu M, Aoki T. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Oncol Rep. 2011 Dec;26(6):1399-406.
19.Itoi T, Kasuya K, Abe Y, Isayama H. Endoscopic placement of a new short-term biodegradable pancreatic and biliary stent in an animal model: a preliminary feasibility study (with videos). J Hepatobiliary Pancreat Sci. 2011 May;18(3):463-7.
20.Kasuya K, Shimazu M, Abe Y, Kikuchi S, Itoi T, Ikada Y, Aoki T, Tsuchida A. A newly developed degradable stent for pancreaticojejunostomy after pancreatoduodenectomy. Int Surg. 2010 Jul-Sep;95(3):247-56. PubMed PMID: 21067005.
21.Abe Y, Urakami H, Ostanin D, Zibari G, Hayashida T, Kitagawa Y, Grisham MB. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts. PLoS One. 2009 Nov 23;4(11):e7840.
22.Abe Y, Hines IN, Zibari G, Pavlick K, Gray L, Kitagawa Y, Grisham MB. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med. 2009 Jan 1;46(1):1-7.
23.Abe Y, Hines I, Zibari G, Grisham MB. Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury. Arch Biochem Biophys. 2009 Apr 15;484(2):232-7.
24.Urakami H, Abe Y, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury. Clin Exp Pharmacol Physiol. 2007 Sep;34(9):912-9.
25.Morise Z, Yamafuji K, Tsuji T, Asami A, Takeshima K, Hayashi N, Baba H, Yoshida F, Abe Y, Tokura Y. A giant retention cyst of the pancreas (cystic dilatation of dorsal pancreatic duct) associated with pancreas divisum. J Gastroenterol. 2002;37(12):1079-82.

ページトップへ